31 related articles for article (PubMed ID: 10428188)
1. Initial validation of the expectancies for Benzodiazepine Analgesia Scale.
Lape EC; Powers JM; LaRowe LR; Ditre JW
Exp Clin Psychopharmacol; 2024 Jun; 32(3):369-378. PubMed ID: 38010761
[TBL] [Abstract][Full Text] [Related]
2. The benzodiazepine dependence questionnaire: development, reliability and validity.
Baillie AJ; Mattick RP
Br J Psychiatry; 1996 Sep; 169(3):276-81. PubMed ID: 8879712
[TBL] [Abstract][Full Text] [Related]
3. The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept study.
Brunner LM; Riebel M; Wein S; Koller M; Zeman F; Huppertz G; Emmer T; Eberhardt Y; Schwarzbach J; Rupprecht R; Nothdurfter C
Trials; 2024 Apr; 25(1):274. PubMed ID: 38650030
[TBL] [Abstract][Full Text] [Related]
4. Blended care to discontinue benzodiazepine receptor agonists use in patients with chronic insomnia disorder: a pragmatic cluster randomized controlled trial in primary care.
Coteur K; Henrard G; Schoenmakers B; Laenen A; Van den Broeck K; De Sutter A; Anthierens S; Devroey D; Kacenelenbogen N; Offermans AM; Van Nuland M
Sleep; 2023 Apr; 46(4):. PubMed ID: 36413221
[TBL] [Abstract][Full Text] [Related]
5. Dependence on hypnotics: a comparative study between chronic users of benzodiazepines and Z-drugs.
Curado DF; de Barros VV; Noto AR; Opaleye ES
Braz J Psychiatry; 2022; 44(3):248-256. PubMed ID: 34133689
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study.
Inoue Y; Takaesu Y; Koebis M
BMC Psychiatry; 2021 Apr; 21(1):193. PubMed ID: 33853571
[TBL] [Abstract][Full Text] [Related]
7. A Qualitative Study of Use of Mindfulness to Reduce Long-Term Use of Habit-Forming Prescription Drugs.
Dundas I; Ravnanger K; Binder PE; Stige SH
Front Psychiatry; 2020; 11():493349. PubMed ID: 33281633
[No Abstract] [Full Text] [Related]
8. Psychometric properties of the Benzodiazepine Dependence Self-Report Questionnaire - Portuguese Version (BENDEP-SRQ-PV).
Curado DF; Barros VV; Opaleye ES; Noto AR
Trends Psychiatry Psychother; 2020; 42(4):358-367. PubMed ID: 33263708
[TBL] [Abstract][Full Text] [Related]
9. Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire.
Yamamoto M; Inada K; Enomoto M; Habukawa M; Hirose T; Inoue Y; Ishigooka J; Kamei Y; Kitajima T; Miyamoto M; Shinno H; Nishimura K; Ozone M; Takeshima M; Suzuki M; Yamashita H; Mishima K
Neuropsychopharmacol Rep; 2021 Mar; 41(1):14-25. PubMed ID: 33259705
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a blended care programme for the discontinuation of benzodiazepine use for sleeping problems in primary care: study protocol of a cluster randomised trial, the Big Bird trial.
Coteur K; Van Nuland M; Vanmeerbeek M; Henrard G; Anthierens S; Van den Broeck K; De Sutter A; Creupelandt H; Devroey D; Van Overmeire R; Offermans AM; Kacenelenbogen N; Laenen A; Mathei C
BMJ Open; 2020 Feb; 10(2):e033688. PubMed ID: 32075832
[TBL] [Abstract][Full Text] [Related]
11. High dose benzodiazepines prolong reaction times in chronic users who have major depressive and/or anxiety disorders.
Manthey L; van Loenen-Frösch F; Giltay EJ; van Veen T; Glashouwer K; Penninx BW; Zitman FG
Br J Clin Pharmacol; 2014 Mar; 77(3):571-7. PubMed ID: 23962205
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine dependence among multidrug users in the club scene.
Kurtz SP; Surratt HL; Levi-Minzi MA; Mooss A
Drug Alcohol Depend; 2011 Dec; 119(1-2):99-105. PubMed ID: 21708434
[TBL] [Abstract][Full Text] [Related]
13. Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users.
Kan CC; Breteler MH; Timmermans EA; van der Ven AH; Zitman FG
Compr Psychiatry; 1999; 40(4):283-91. PubMed ID: 10428188
[TBL] [Abstract][Full Text] [Related]
14. Cross-validation of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users.
Kan CC; Breteler MH; van der Ven AH; Zitman FG
Compr Psychiatry; 2001; 42(5):433-9. PubMed ID: 11559871
[TBL] [Abstract][Full Text] [Related]
15. Assessment of benzodiazepine dependence in alcohol and drug dependent outpatients: a research report.
Kan CC; Breteler MH; van der Ven AH; Timmermans MA; Zitman FG
Subst Use Misuse; 2001 Jun; 36(8):1085-109. PubMed ID: 11504154
[TBL] [Abstract][Full Text] [Related]
16. Cross-validation, predictive validity, and time course of the Benzodiazepine Dependence Self-Report Questionnaire in a benzodiazepine discontinuation trial.
Oude Voshaar RC; Mol AJ; Gorgels WJ; Breteler MH; van Balkom AJ; van de Lisdonk EH; Kan CC; Zitman FG
Compr Psychiatry; 2003; 44(3):247-55. PubMed ID: 12764713
[TBL] [Abstract][Full Text] [Related]
17. WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results.
Ustün B; Compton W; Mager D; Babor T; Baiyewu O; Chatterji S; Cottler L; Göğüş A; Mavreas V; Peters L; Pull C; Saunders J; Smeets R; Stipec MR; Vrasti R; Hasin D; Room R; Van den Brink W; Regier D; Blaine J; Grant BF; Sartorius N
Drug Alcohol Depend; 1997 Sep; 47(3):161-9. PubMed ID: 9306042
[TBL] [Abstract][Full Text] [Related]
18. Measuring addiction propensity and severity: the need for a new instrument.
Conway KP; Levy J; Vanyukov M; Chandler R; Rutter J; Swan GE; Neale M
Drug Alcohol Depend; 2010 Sep; 111(1-2):4-12. PubMed ID: 20462706
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
